fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Poster Session at ECC 2013 – Circulating tumour cell counts in advanced and metastatic colorectal cancer by immunomagnetic labelling: Results reflect the reality?

Written by | 2 Dec 2013

Solange M Sanches et al, AC Camargo Cancer Center, São Paulo, Brazil.

Poster Session at ECC 2013 – Younger patients at high risk

Written by | 2 Dec 2013

Discussion of the abstract by Dr Christopher Lieu, MD, Assistant professor at the University of Colorado.  Younger patients with colorectal cancer that has spread (metastasised) to other parts… read more.

Poster Session at ECC 2013 – How to endure life during treatment for colorectal cancer

Written by | 29 Nov 2013

Birgitte Pedersen et al, Vejle Hospital, Denmark.  Patients with colorectal cancer (CRC) face huge challenges in their everyday lives as a result of their condition and treatments.

Poster Session at ECC 2013 – Screening in colorectal cancer works

Written by | 29 Nov 2013

Discussion of the abstract by Professor Philippe Autier, Vice President, Population Studies, at the International Prevention Research Institute, Lyon, France.

Poster Session at ECC 2013 – Biology of the tumour key to treatment

Written by | 28 Nov 2013

Discussion of the abstract by Dr Zoran Gatalica, Adjunct Professor of Pathology at Creighton University School of Medicine .

Poster Session at ECCO 2013 – Aspirin unmasks tumour cells

Written by | 28 Nov 2013

Oral discussion of abstract by Professor Naredi, Sahlgrenska University Hospital, Gothenburg, Sweden.   Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer. 

ECC 2013 Report: Joint ECCO/BDA Special Session: Accelerating patient access to innovative drugs in Europe

Written by | 27 Nov 2013

by Peter Mas Mollinedo – Improvements in diagnostics and medical treatments mean the number of patients living with cancer is increasing around the world. The World Health Organization… read more.

ECC 2013 Report – Role of aggressive surgery for peritoneal metastases

Written by | 27 Nov 2013

by Peter Mas Mollinedo reporting on the presentation by Dominique Elias, Gustave-Roussy Institute, Paris, France.  – Aggressive complete cytoreductive surgery (CCRS) in combination with hyperthermic intraperitoneal chemotherapy (HIPEC)… read more.

ACR/ARHP 2013 Report – Aggressive combination treatment is more effective in juvenile idiopathic arthritis

Written by | 20 Nov 2013

Children with juvenile idiopathic arthritis (JIA) undergoing early and aggressive combination drug  therapy  achieve clinical inactive disease more quickly than with less aggressive therapy, researchers reported at  the… read more.

Smoking cessation drugs do not increase suicide/self-harm risk

Written by | 18 Nov 2013

by Bruce Sylvester – taken from the BMJ – British Medical Journal – Patients prescribed the smoking cessation drugs varenicline and buproprian are not at an increased risk… read more.

ECC 2013: Late Breaking Clinical Trials: ASPECCT

Written by | 15 Nov 2013

by Esther Drain reporting on the presentation by Dr Timothy Price – A randomized, multicenter, open-label, phase 3 study of panitumumab (pmab) vs cetuximab (cmab) for previously treated… read more.

Video Interview: Professor Lenz and Professor Heinemann explain how they see biomarker testing in mCRC developing in practice following discussions at the ECC

Written by | 13 Nov 2013

Taken from the European Cancer Congress ( ECCO /  ESMO / ESTRO ) from the 27th September – 1st October 2013 in Amsterdam.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.